Authors
Loading...
Molecular docking revealed binding to TrmD in bacterial enzymes, suggesting enhanced biofilm disruption by new benzimidazole-thienopyrimidine hybrids.
Vlasova et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: